openPR Logo
Press release

Drug Designing Tools Market to Expand with Significant CAGR During 2027

12-07-2017 11:52 AM CET | Health & Medicine

Press release from: Future Market Insights

Drug Designing Tools Market to Expand with Significant CAGR

Drug designing tools are software and databases that are used at an early stage of modern drug discovery process. The use of computers and computational tools have permeated all aspects of drug-discovery and have formed essential part of structure-based drug design. Drug discovery and development is tremendous lengthy process involving multiple disciplines such as chemistry, biology, biophysics, structural biology and computational science. Typical drug discovery starts with target identification, lead discovery & optimization, pre-clinical in vitro and in vivo studies involving approximately 12 to 14 years and costs up to US$ 1.2 to 1.4 Bn. However, in silico screening of chemical database has now become the important tool to reduce the time, cost and chances of failure of lead at later stage of development. Computer aided drug designing or in silico drug designing has gained significant momentum in past 3 decades. There are different techniques used in in silico drug designing and including visualization, molecular dynamics simulation, homology, energy minimization tools, molecular docking etc. drug discovery tools can be used in all stages of drug development including discovery pre-clinical and clinical stage. Today all pharmaceutical and biotechnology companies take the advent of drug designing tools to cut down the time and resources required in drug development process and modern drug discovery is almost impossible without the use of computational tools. Thus market for drug designing tools is ever growing with rapid technological advancements developments.

Read Report Overview @ https://www.futuremarketinsights.com/reports/drug-designing-tools-market

The primary factor driving the growth of global drug designing tools market is increasing pace of research and development in all verticals of pharmaceutical, biotechnology and life science industries. Moreover, immediate need of medicines to treat chronic diseases such as cancer, diabetes, etc., increasing complexity of drug discovery due to huge amount of biological data, need for simplified ways to handle big data generated during drug discovery process, growing stringency in regulations for animal handling, etc. are some others factors fueling the demand for drug designing tools. The only factors hampering the growth of global drug designing tools market are high cost of such tools and lack of skilled professionals to operate the tools.

The global market for drug designing tools is highly consolidated and very few number of big players constitute 70% the entire market. Development of drug designing tools also require huge investment of time and is thus limited to IT giants.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3806

Geographically, drug designing tools market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to be the leader in global drug designing tools market owing to increasing pace and capability of research and development. Europe is expected to be the second largest market for drug designing tools. The market in Asia Pacific and Japan is expected to grow at significant CAGR due to increasing academic research activities and growing number of academic institutes. Market in MEA and Eastern Europe is expected to witness sluggish growth over the forecast period.

Some of the major players in the drug designing tools market are Schrödinger LLC, Gaussian Inc., Accelrys, BioSolveIT GmbH, COSMOlogic GmbH & Co., Certara, L.P, PerkinElmer Inc., Simulations Plus, ChemAxon, OpenEye Scientific Software Inc., in silico toxicology gmbh among others.

Buy Full Drug Designing Tools Market Report @ https://www.futuremarketinsights.com/checkout/3806

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Designing Tools Market to Expand with Significant CAGR During 2027 here

News-ID: 849832 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug